SEC Form 4 · accession 0001209191-15-064801
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Geraghty
Director
Period of report
Aug 6, 2015
Accepted (ET)
Aug 10, 2015 · 11:15 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| JNP Stock on Open MarketF1 | Aug 6, 2015 | P | 12,000 | $10.46 | A | 33,011 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at an average price of $10.46. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon further request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected.